Nasser Khaled Altorki
NewYork–Presbyterian Hospital · 682 works · 40,279 citations · h-index 92
Top works
- Early Lung Cancer Action Project: overall design and findings from baseline screening
- VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche
- Early Lung Cancer Action Project
- Thoracoscopic lobectomy is associated with lower morbidity than open lobectomy: A propensity-matched analysis from the STS database
- Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB–IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial
- Lobar or Sublobar Resection for Peripheral Stage IA Non–Small-Cell Lung Cancer
- Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance
- Three-Field Lymph Node Dissection for Squamous Cell and Adenocarcinoma of the Esophagus
- High-grade dysplasia in the columnar-lined esophagus
- The Number of Lymph Nodes Removed Predicts Survival in Esophageal Cancer: An International Study on the Impact of Extent of Surgical Resection
- Occult cervical nodal metastasis in esophageal cancer: Preliminary results of three-field lymphadenectomy
- Immunohistochemical analysis of NY-ESO-1 antigen expression in normal and malignant human tissues
- CT-guided transthoracic needle biopsy of small solitary pulmonary nodules
- Curcumin inhibits cyclooxygenase-2 transcription in bile acid- and phorbol ester-treated human gastrointestinal epithelial cells
- Cyclo-oxygenase 2: a pharmacological target for the prevention of cancer
- TOX is a critical regulator of tumour-specific T cell differentiation
- Elevated Preoperative Neutrophil:Lymphocyte Ratio as a Predictor of Postoperative Disease Recurrence in Esophageal Cancer
- En bloc esophagectomy improves survival for stage III esophageal cancer
- Adjuvant Erlotinib Versus Placebo in Patients With Stage IB-IIIA Non–Small-Cell Lung Cancer (RADIANT): A Randomized, Double-Blind, Phase III Trial
- Should En Bloc Esophagectomy Be the Standard of Care for Esophageal Carcinoma?